Molecular Diagnostics

Non-coding Regions of the Genome in Microglia Linked to Alzheimer’s Disease Risk
A recently published paper linked risk of developing Alzheimer’s disease (AD) to enhancers - non-coding DNA regions of the genome - that were present in microglia but not in other types of brain cells such as neurons or astrocytes. More...28 Nov 2019


LDL Subclasses Ratio Predicts Cardiovascular Disease Risk More Accurately than LDL-cholesterol Alone
Measurement of low-density lipoprotein (LDL) cholesterol may a less effective way to predict risk of cardiovascular disease than is the further analysis of the relative proportions of LDL subclasses. More...27 Nov 2019

Mycobacterium Infection Found in Gastric Patients’ Stomachs
Development of gastric diseases such as gastritis, peptic ulcer and gastric cancer is often associated with several biotic and abiotic factors. Helicobacter pylori infection is such a well-known biotic factor. However, not all H. pylori-infected individuals develop gastric diseases and not all individuals with gastric diseases are infected with H. pylori. More...26 Nov 2019

Novel, High-Accuracy Blood Test Can Screen for Multiple Cancers
A new targeted methylation-based assay has been developed that is able to screen blood samples for more than 20 types of cancer at all stages, including lung cancer, with high accuracy and it also correctly pinpoints the tissue of origin (TOO). More...26 Nov 2019

Crohn's Disease-Associated Bacteria Tolerate Antibiotics
Crohn's disease is a chronic disease that causes inflammation and irritation in the digestive tract. The disease is characterized by an imbalance in the intestinal microbiome. In particular, adherent-invasive Escherichia coli (AIEC) strains have been implicated in the disease. More...26 Nov 2019
In Other News
Breast Cancer Recurrence Risk Predicted by Immune-Related Germline Variants
Aqueous Humor Is Superior to Blood to Diagnose Retinoblastoma
A Potential Point-of-Care Method for the Diagnosis of Sepsis
Novel Nanosensing Technologies Developed for Exosome Detection and Profiling
Blood Biomarkers Identify Individuals at Risk of Heart Attack or Stroke
Biomarker in Stools Helps to Diagnose Necrotizing Enterocolitis in Premature Babies
Early-Onset Alzheimer's Mutation Possibly Mitigated by APOE Variant
Project Set to Develop Algorithm Able to Accurately Predict and Detect Sepsis
Phoenix CPO Test Evaluated for Detection of Carbapenemase Producers
Rapid Fluorescence Fingerprinting Assay for Identification of Synthetic Cannabinoid Receptor Agonists
Newly Identified Biomarker Distinguishes Potentially Aggressive Meningiomas
Rapid DNA Flow Technology Platform Detects Tick-Borne Bacterial Pathogens
Researchers Recommend the Membrane Protein Flotillin as a Biomarker for Alzheimer’s Disease
Inexpensive LAMP-Based Schistosomiasis Tests Developed
Chromosomal Abnormalities Associated with Recurrent Miscarriage
Use of Cell-free DNA Liquid Biopsy to Predict Glioblastoma Progression
Prostate Cancer Methylation Levels Linked to Epigenetic Profiles
Metabolomic Profiling Identifies ALL Patients at Risk for MRD and Cancer Relapse
Enterovirus D type 111 Genetically and Phenotypically Characterized
Whole-exome Sequencing Identifies Mysterious Pancreatitis Mutation
Metastatic Tumor Profiles Lead to Potential Treatment Targets
Full Analytical Data Validated for Target Selector ctDNA Assays
Blood and Urine Metabolic Biomarkers Monitor Short-term Dietary Changes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








